Select Publications
Conference Papers
2016, 'The impact of prior use of four preventive medications on outcomes in patients hospitalized for acute coronary syndrome-Results from CPACS-2 Study', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, PEOPLES R CHINA, Beijing, pp. C96 - C96, presented at 27th Great Wall Int Congress of Cardiol / 21st Annual Sci Meeting of the Int-Soc-of-Cardiovascular-Pharmacotherapy / World Heart Failure Congress / Int Congress of Cardiovascular Prevent and Rehabilitat, PEOPLES R CHINA, Beijing, 13 October 2016 - 16 October 2016, http://dx.doi.org/10.1016/j.jacc.2016.07.359
,2016, 'Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (< 70mg/dl): data from CPACS studies', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, ITALY, Rome, pp. 1166 - 1166, presented at Congress of the European-Society-of-Cardiology (ESC), ITALY, Rome, 27 August 2016 - 31 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383869505586&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'PS 14-28 EFFICACY AND SAFETY OF COMBINATION OF THREE OR MORE BP LOWERING DRUGS FOR THE MANAGEMENT OF HIGH BLOOD PRESSURE', in Journal of Hypertension, Wolters Kluwer, pp. e442, http://dx.doi.org/10.1097/01.hjh.0000501151.39883.3b
,2014, 'Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme', in LANCET, ELSEVIER SCIENCE INC, MA, Harvard Med Sch, Boston, pp. 23 - 23, presented at Lancet Commission on Global Surgery Meeting, MA, Harvard Med Sch, Boston, 17 January 2014 - 18 January 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360573400024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'The predictors of discharge without clopidogrel following admission with acute coronary syndrome in australia - the concordance registry', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 23 - 23, presented at Congress of the European-Society-of-Cardiology (ESC), NETHERLANDS, Amsterdam, 31 August 2013 - 04 September 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327744600073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'PREDICTING BLEEDING IN AN ACS POPULATION', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, CA, San Francisco, pp. E138 - E138, presented at 62nd Annual Scientific Session of the American-College-of-Cardiology, CA, San Francisco, 09 March 2013 - 11 March 2013, http://dx.doi.org/10.1016/S0735-1097(13)60139-4
,2012, 'HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885002156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The Influence of Alcohol Use on Vascular Complications and Mortality in Patients with Type 2 Diabetes Mellitus', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885003421&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885003395&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE)', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, CA, Los Angeles, pp. 2781 - 2781, presented at Scientific Sessions of the American-Heart-Association, CA, Los Angeles, 03 November 2012 - 07 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311937200032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'HealthTracker: does electronic decision support improve identification and management of cardiovascular risk in australian primary health care', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, U ARAB EMIRATES, Dubai, pp. E808 - E808, presented at World Congress of Cardiology Scientific Sessions, U ARAB EMIRATES, Dubai, 18 April 2012 - 21 April 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307009201084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Socioeconomic gradients in cardiovascular risk factor prevalence and screening, and in knowledge of determinants of cardiovascular disease, in rural India', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702701215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Intensive glucose control is renoprotective in type 2 diabetes: New analyses from ADVANCE', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, pp. S98 - S98, presented at 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD), SWEDEN, Stockholm, 20 September 2010 - 24 September 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280689700222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Patterns of use of glucose lowering treatments at baseline and during follow-up in ADVANCE', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, presented at 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD), SWEDEN, Stockholm, 20 September 2010 - 24 September 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280689701349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'A NEW MODEL FOR PREDICTING THE RISK OF MAJOR CARDIOVASCULAR OUTCOMES IN PEOPLE WITH DIABETES', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Sydney, pp. 1501 - 1501, presented at 31st Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Sydney, 01 December 2009 - 03 December 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000277848100076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Sydney, pp. 1502 - 1502, presented at 31st Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Sydney, 01 December 2009 - 03 December 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000277848100081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1115 - 1115, presented at 30th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Melbourne, 03 December 2008 - 05 December 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266239300116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1103 - 1103, presented at 30th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Melbourne, 03 December 2008 - 05 December 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266239300059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'THE 4-YEAR PREDICTED RISK OF TOTAL CARDIOVASCULAR DISEASE IN THE ADVANCE POPULATION: PERFORMANCE OF THE FRAMINGHAM RISK EQUATIONS', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1110 - 1110, presented at 30th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, AUSTRALIA, Melbourne, 03 December 2008 - 05 December 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266239300092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: A randomised controlled trial', in DIABETOLOGIA, SPRINGER, ITALY, Rome, pp. S476 - S476, presented at 44th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ITALY, Rome, 07 September 2008 - 11 September 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258660201464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A121 - A121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652600086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'THE IDENTIFICATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE (CKD) AND RISK FACTORS IN ABORIGINAL PRIMARY HEALTH CARE', in NEPHROLOGY, WILEY-BLACKWELL, pp. A123 - A124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652600093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S189 - S189, presented at 18th Scientific Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, GERMANY, Berlin, 14 June 2008 - 19 June 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257197001234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Advances in reducing the burden of vascular disease in type 2 diabetes', in Clinical and Experimental Pharmacology and Physiology, pp. 434 - 437, http://dx.doi.org/10.1111/j.1440-1681.2008.04892.x
,2008, 'Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region', in DIABETES RESEARCH AND CLINICAL PRACTICE, ELSEVIER IRELAND LTD, pp. S7 - S7, http://dx.doi.org/10.1016/S0168-8227(08)70661-2
,2007, 'Does total cholesterol have a similar relationship with coronary heart disease, and ischaemic and haemorrhagic strokes in people with and without diabetes?', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702202371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Can NT-proBNP monitoring help prevent cardiovascular disease?', in Kimchi A (ed.), RECENT ADVANCES IN CARDIOVASCULAR DISEASE: PROCEEDINGS OF THE 13TH WORLD CONGRESS HEART DISEASE, MEDIMOND S R L, CANADA, Vancouver, pp. 331 - +, presented at 13th World Congress on Heart Disease, CANADA, Vancouver, 28 July 2007 - 31 July 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257311100061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'The impact of cigarette smoking on cardiovascular disease amongst women and men in the Asia-Pacific region', in EPIDEMIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, SOUTH AFRICA, Johannesburg, pp. S41 - S42, presented at 17th Annual Conference of the International-Society-for-Environmental-Epidemiology, SOUTH AFRICA, Johannesburg, 13 September 2005 - 16 September 2005, http://dx.doi.org/10.1097/00001648-200509000-00093
,2004, 'Risk factors for subarachnoid haemorrhage: Evidence from the Asia Pacific Cohort studies collaboration', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Vancouver, pp. E235 - E235, presented at 5th World Stroke Congress, CANADA, Vancouver, 23 June 2004 - 26 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000221676600484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Serum triglycerides and the risk of cardiovascular disease in the Asia Pacific Region: An individual participant data meta-analysis of cohort studies including 96,130 individuals', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, LA, New Orleans, pp. 462A - 462A, presented at 54th Annual Scientific Session of the American-College-of-Cardiology, LA, New Orleans, 07 March 2004 - 10 March 2004, http://dx.doi.org/10.1016/S0735-1097(04)91955-9
,2002, 'Managing the global burden of cardiovascular disease', in European Heart Journal, Supplement, http://dx.doi.org/10.1016/S1520-765X(02)90022-2
,2001, 'Blood pressure lowering in diabetes: A brief review of the current evidence and description of a new trial', in Clinical and Experimental Pharmacology and Physiology, pp. 1108 - 1111, http://dx.doi.org/10.1046/j.1440-1681.2001.03581.x
,